Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism

Name: Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Health Canada reviewed this issue because a published study found a link between SSRI exposure during pregnancy and an increased risk of autism in children. Autism is a developmental disability with lifelong impact. It affects a child's ability to communicate and interact with others.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2024-05-10

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism (English, HTML) HTML
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism (French, HTML) HTML

Related open data

Health Canada